Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 119889
Published online Sep 15, 2026. doi: 10.4251/wjgo.119889
Published online Sep 15, 2026. doi: 10.4251/wjgo.119889
Table 1 Baseline demographic and clinical characteristics of the study population, n (%)
| Characteristics | Total cohort (n = 383) | Beijing Friendship Hospital (n = 302) | Beijing Tiantan Hospital (n = 81) |
| Age (years), mean ± SD | 66.7 ± 12.5 | 67.2 ± 12.2 | 64.8 ± 13.1 |
| Gender | |||
| Male | 202 (52.7) | 162 (53.6) | 40 (49.4) |
| Female | 181 (47.3) | 140 (46.4) | 41 (50.6) |
| Class distribution | |||
| Cancerous | 225 (58.7) | 181 (59.9) | 44 (54.3) |
| Noncancerous | 158 (41.3) | 121 (40.1) | 37 (45.7) |
| Lesion subtypes | |||
| Cancerous group | |||
| Pancreatic ductal adenocarcinoma | 219 (57.2) | 176 (58.3) | 43 (53.1) |
| Pancreatic acinar cell carcinoma | 6 (1.6) | 5 (1.7) | 1 (1.2) |
| Noncancerous group | |||
| Solid pseudopapillaryoma | 72 (18.8) | 56 (18.5) | 16 (19.8) |
| Autoimmune pancreatitis | 55 (14.4) | 41 (13.6) | 14 (17.3) |
| Neuroendocrine neoplasms | 31 (8.1) | 24 (7.9) | 7 (8.6) |
Table 2 Dual-center energy statistics for the two hospitals
| Center | Mean | SD | Min | Max |
| Center A_0 | 0.061474 | 0.056234 | 0.008741 | 0.559571 |
| Center A_1 | 0.047896 | 0.040044 | 0.009132 | 0.320019 |
| Center B_0 | 0.021291 | 0.009237 | 0.007514 | 0.047186 |
| Center B_1 | 0.023628 | 0.017217 | 0.009367 | 0.120883 |
Table 3 Internal validation results
| Methods | Precision (%) (95%CI)↑ | Sensitivity (%) (95%CI)↑ | Accuracy (%) (95%CI)↑ | Specificity (%) (95%CI)↑ | F1 score (%) (95%CI)↑ |
| ResNet-50a | 86.96 (82.17-90.95) | 94.14 (91.47-97.49) | 89.12 (86.41-92.05) | 82.76 (77.43-88.30) | 90.50 (87.76-93.16) |
| Swin_transformera | 89.29 (83.64-92.31) | 94.34 (90.48-96.97) | 90.53 (86.92-92.82) | 85.71 (79.89-90.64) | 91.74 (88.02-93.65) |
| MedViTV2a | 90.09 (85.32-93.24) | 95.24 (91.54-97.66) | 91.50 (87.95-93.85) | 86.75 (81.71-91.33) | 92.59 (89.20-94.48) |
| MCEUS-C2Net (ours) | 93.46 (89.08-95.97) | 97.09 (95.48-99.51) | 94.51 (92.31-96.67) | 91.14 (86.70-94.92) | 95.24 (93.01-97.01) |
Table 4 External validation results
| Methods | Precision (%) (95%CI)↑ | Sensitivity (%) (95%CI)↑ | Accuracy (%) (95%CI)↑ | Specificity (%) (95%CI)↑ | F1 score (%) (95%CI)↑ |
| ResNet-50b | 84.57 (79.00-89.88) | 74.00 (67.88-80.49) | 78.65 (74.32-82.97) | 84.12 (78.31-89.51) | 78.93 (74.13-83.42) |
| Swin_transformerb | 86.63 (81.87-91.24) | 81.00 (75.26-86.26) | 82.97 (78.92-86.49) | 85.29 (79.88-90.30) | 83.72 (79.49-87.35) |
| MedViTV2a | 86.57 (82.03-91.35) | 87.00 (82.16-91.67) | 85.68 (82.16-89.19) | 84.12 (78.33-89.54) | 86.78 (83.24-90.10) |
| MCEUS-C2Net (ours) | 91.88 (87.75-95.26) | 90.50 (86.47-94.23) | 90.59 (87.84-93.51) | 90.59 (85.98-94.51) | 91.18 (88.32-93.77) |
Table 5 Ablation study results on the internal validation set
| Methods | Precision (%) (95%CI)↑ | Sensitivity (%) (95%CI)↑ | Accuracy (%) (95%CI)↑ | Specificity (%) (95%CI)↑ | F1 score (%) (95%CI)↑ |
| GFEb | 86.85 (82.25-91.39) | 88.10 (83.76-92.56) | 86.41 (82.82-89.74) | 84.44 (79.28-89.64) | 87.47 (83.99-90.70) |
| LFEb | 88.73 (84.46-92.72) | 90.00 (85.92-93.97) | 88.46 (85.13-91.54) | 86.67 (81.82-91.33) | 89.36 (86.15-92.38) |
| LFE + CSAb | 90.05 (85.86-93.91) | 90.48 (86.57-94.45) | 89.49 (86.41-92.56) | 88.33 (83.60-92.90) | 90.26 (87.12-93.15) |
| LFE + GFEa | 90.09 (85.32-93.24) | 95.24 (91.54-97.66) | 91.50 (87.95-93.85) | 86.75 (81.71-91.33) | 92.59 (89.20-94.48) |
| MCEUS-C2Net (ours) | 93.46 (89.08-95.97) | 97.09 (95.48-99.51) | 94.51 (92.31-96.67) | 91.14 (86.70-94.92) | 95.24 (93.01-97.01) |
Table 6 Ablation study results on the external validation set
| Methods | Precision (%) (95%CI)↑ | Sensitivity (%) (95%CI)↑ | Accuracy (%) (95%CI)↑ | Specificity (%) (95%CI)↑ | F1 score (%) (95%CI)↑ |
| GFEb | 83.62 (78.15-89.10) | 74.00 (67.88-80.49) | 78.11 (73.78-82.43) | 82.94 (77.06-88.54) | 78.51 (73.63-82.95) |
| LFEb | 86.71 (81.39-92.03) | 75.00 (68.93-81.42) | 80.27 (75.95-84.32) | 86.47 (81.03-91.47) | 80.43 (75.80-84.85) |
| LFE + CSAb | 87.10 (82.18-92.19) | 81.00 (75.50-86.46) | 83.24 (79.18-87.30) | 85.88 (80.46-91.14) | 83.94 (79.77-87.77) |
| LFE + GFEa | 86.57 (82.03-91.35) | 87.00 (82.16-91.67) | 85.68 (82.16-89.19) | 84.12 (78.33-89.54) | 86.78 (83.24-90.10) |
| MCEUS-C2Net (ours) | 91.88 (87.75-95.26) | 90.50 (86.47-94.23) | 90.59 (87.84-93.51) | 90.59 (85.98-94.51) | 91.18 (88.32-93.77) |
- Citation: Yu XY, Ye JQ, He Z, He Q. Multicenter deep learning model for pancreatic cancer detection using endoscopic ultrasound. World J Gastrointest Oncol 2026; 18(9): 119889
- URL: https://www.wjgnet.com/1948-5204/full/v18/i9/119889.htm
- DOI: https://dx.doi.org/10.4251/wjgo.119889